Soleno Therapeutics (SLNO) Cash & Current Investments (2016 - 2019)
Historic Cash & Current Investments for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to $11.2 million.
- Soleno Therapeutics' Cash & Current Investments rose 962.98% to $11.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was $11.2 million, marking a year-over-year increase of 962.98%. This contributed to the annual value of $23.1 million for FY2018, which is 3508.19% up from last year.
- According to the latest figures from Q3 2019, Soleno Therapeutics' Cash & Current Investments is $11.2 million, which was up 962.98% from $15.5 million recorded in Q2 2019.
- In the past 5 years, Soleno Therapeutics' Cash & Current Investments ranged from a high of $23.1 million in Q4 2018 and a low of $2.5 million during Q2 2016
- In the last 5 years, Soleno Therapeutics' Cash & Current Investments had a median value of $9.5 million in 2015 and averaged $10.1 million.
- As far as peak fluctuations go, Soleno Therapeutics' Cash & Current Investments soared by 727500.0% in 2015, and later plummeted by 6677.29% in 2016.
- Soleno Therapeutics' Cash & Current Investments (Quarter) stood at $5.5 million in 2015, then plummeted by 50.39% to $2.7 million in 2016, then surged by 527.29% to $17.1 million in 2017, then surged by 35.08% to $23.1 million in 2018, then crashed by 51.4% to $11.2 million in 2019.
- Its Cash & Current Investments was $11.2 million in Q3 2019, compared to $15.5 million in Q2 2019 and $19.4 million in Q1 2019.